Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» LY-CoV-55
LY-CoV-55
Eli Lilly gets FDA EUA status for bamlanivimab to treat Covid-19
Pharmaceutical Business Review
Tue, 11/10/20 - 10:44 am
Eli Lilly
Emergency Use Authorizations
FDA
LY-CoV-55
COVID-19
antibodies
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Fierce Pharma
Thu, 09/17/20 - 10:56 am
Eli Lilly
Amgen
LY-CoV-55
antibody cocktail
COVID-19